These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 6165191)

  • 1. Pronounced formation of 5-OH-dopa at enzymatic oxidation of DOPA in the presence of ascorbic acid.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1981; 61(2):147-8. PubMed ID: 6165191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
    Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase activity in the medium of human melanoma cell cultures.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cysteine on oxidation of tyrosine, dopa, and cysteinyldopas.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Arch Dermatol Res; 1982; 272(1-2):103-15. PubMed ID: 6819815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of dopa in the skin of black and albino mice.
    Carstam R; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1986; 66(5):369-74. PubMed ID: 2431571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
    Ito S; Kato T; Shinpo K; Fujita K
    Biochem J; 1984 Sep; 222(2):407-11. PubMed ID: 6433900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of 5-S-glutathionyldopa.
    Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of tyrosinase by dopa.
    Tomita Y; Hariu A; Mizuno C; Seiji M
    J Invest Dermatol; 1980 Nov; 75(5):379-82. PubMed ID: 6776205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular distribution of dopa and 5-S-cysteinyldopa in pigment cells with minimal pigment formation.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(4):355-6. PubMed ID: 92151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraweak photon emission in model reactions of the in vitro formation of eumelanins and pheomelanins.
    Sławińska D; Sławiński J
    Pigment Cell Res; 1987; 1(3):171-5. PubMed ID: 3149740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of drugs for dopa-auto-oxidation melanin and tyrosinase-catalyzed dopa-melanin in vitro.
    Hayasaka S; Tsuchiya M; Noda S; Setogawa T; Mizuno K
    Ophthalmic Res; 1988; 20(6):376-9. PubMed ID: 3148876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxylation of tyrosine by plant peroxidase and mushroom tyrosinase, with and without hydrazine, to retard the oxidation of dopa.
    Patel RP; Okun MR
    Physiol Chem Phys; 1977; 9(1):85-9. PubMed ID: 410043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure.
    Wakamatsu K; Ohtara K; Ito S
    Pigment Cell Melanoma Res; 2009 Aug; 22(4):474-86. PubMed ID: 19493317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of 6-hydroxydopa by human tyrosinase.
    Hansson C; Rorsman H; Rosengren E; Wittbjer A
    Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron spin resonance studies on phaeomelanins.
    Hansson C; Agrup G; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1979; 59(5):453-6. PubMed ID: 93370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of conditions for preparing synthetic pheomelanin.
    Ito S
    Pigment Cell Res; 1989; 2(1):53-6. PubMed ID: 2497445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.